Consider the following statements regarding glucagon-like peptide-1 (GLP-1) and gastric inhibitory polypeptide (GIP): 1. GLP-1 is an incretin hormone. 2. GIP is an incretin hormone. 3. GLP-1 is released from gastrointestinal 'L-cells'. 4. GIP is released from gastrointestinal 'M-cells'. Which of the statements given above are correct?
1, 2 and 3
GLP-1 and GIP are both incretin hormones (statements 1 and 2 true). GLP-1 is secreted by intestinal L-cells (statement 3 true). GIP, however, is secreted by K-cells of the duodenum/jejunum, not 'M-cells' (statement 4 is false). Hence 1, 2 and 3 are correct.
Similar Questions
Which of the following may be seen during clinical examination in a patient of Diabetes mellitus?
1. Necrobiosis lipoidica
2. Charcot neuroarthropathy
3. Exudative maculopathy
4. Acanthosis nigricans
Select the correct answer using the code given below:
Which of the following are long-acting insulin analogues?
1. Lispro
2. Glargine
3. Detemir
4. Degludec
Select the correct answer using the code given below:
Which one of the following drugs is not a secondary cause of weight gain?
Which one of the following levels of hypoglycaemia corresponds to a blood glucose level of 50 mg/dL leading to cognitive impairment and need for corrective treatment?
Important Questions from Diabetes Mellitus
- All of the following are clinical features of Polycystic ovarian syndrome EXCEPT:
- Which one of the following is NOT the criterion for the diagnosis of Diabetes mellitus?
- Consider the following statements about erectile dysfunction in diabetic males:
1. It affects 60% of males
2. Its common cause is an underlying neuro-vascular pathology
3. It may be aggravated by beta-adrenergic agonist drugs
4. Endocrine disorders like hyperprolactinemia may cause it
Which of the statements given above are true? - Syndrome X includes:
- All of the following insulins are longer acting EXCEPT:
